One of the founders of Sanare has a long experience in promoting self-repairing processes in patients. He has over the years observed that the self-healing can be re-introduced in several levels within the body, through the central nervous system, the blood, through the metabolism and through several different signalling systems, as for instance the oliigopeptide signalling system. Given that all these leves were observed to be in constant communication and interaction, the stimulus of one of the components would induce an effect over to the other levels, as for instance a stimulus carried through the CNS would affect the metabolism, and in turn the rest of the body. After years of research, the focus fell on the oligopeptide system, which is a powerfull and versatile multitude of short peptide chains that affect cellular mechanisms down to the DNA/RNA level. Now at Sanare, the whole process of identifying these oligopeptides and translating them into medicines has been made possible through the application of modern state-of-the-art biotechnologies and has been applied in the case of breast cancer cells MCF7, TMX228 and T47D.